Related Experiment Video
Updated: May 5, 2026
12:27
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
16.2K
Nonmicrobial-mediated inflammatory airway diseases--an update
Polani B Ramesh Babu1, P Krishnamoorthy
1Department of Bioinformatics, Bharath University, Selaiyur, Chennai, India, bioinfohod@gmail.com.
Journal of Physiology and Biochemistry
|December 3, 2013
Summary
Airway epithelium defends lungs against inhaled threats. This review explores how environmental factors, stress, and agents trigger inflammation via molecular mechanisms.
Area of Science:
- Pulmonary immunology
- Cellular biology
- Environmental health
Background:
- The airway epithelium is the primary defense against inhaled environmental factors like microbes and pollutants.
- Innate immune recognition, particularly via toll-like receptors, initiates inflammatory responses to pathogens and tissue damage.
- The immune system detects host insults even without direct microbial stimulation.
Purpose of the Study:
- To review the molecular mechanisms underlying airway inflammation.
- To investigate the role of environmental factors, cellular stress, and pharmacological agents in airway inflammation pathophysiology.
Main Methods:
- Literature review of molecular mechanisms in airway inflammation.
- Analysis of innate immune system pathways, including toll-like receptor signaling.
- Examination of environmental, cellular, and pharmacological triggers of inflammation.
Main Results:
- Environmental factors, cellular stress, and specific agents can initiate and perpetuate airway inflammation.
- Toll-like receptor signaling is a critical gateway for inflammatory responses.
- The airway epithelium employs defense mechanisms to clear inhaled substances while modulating inflammation.
Conclusions:
- Understanding the molecular basis of airway inflammation is crucial for developing targeted therapies.
- Environmental exposures and cellular stress significantly impact lung health by modulating inflammatory pathways.
- The interplay between the airway epithelium and the innate immune system dictates lung responses to diverse insults.
Related Concept Videos
01:28Asthma I: Introduction
311
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
77
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
77
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:12Chronic Inflammation: Introduction
50
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
50